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Introduction
Carotid cavernous fistula (CCF) is an abnormal communica-
tion between the carotid artery and the cavernous sinus. CCF 
is classified according to its etiology (traumatic or spontane-
ous) and anatomy (directly from the carotid artery or from its 
dural branches).
1 Direct CCF is usually traumatic, and dural 
CCF is usually spontaneous.
2 Studies on the factors that pre-
dispose to spontaneous CCF are lacking, and its pathogenesis 
remains unclear.
Protein S is a vitamin-K-dependent plasma protein with an-
ticoagulant activity, a cofactor of activated protein C, and an 
inhibitor of tissue factor pathways during the inactivations of 
factors Va, VIIa, VIIIa, and Xa.
3 The prevalence of protein S 
deficiency in the general population is less than 0.5%, and it 
usually occurs due to a heterozygous defect.
4 Protein S defi-
ciency might predispose a patient to venous thrombosis, and 
may be associated with recurrent thromboembolic diseases 
such as deep vein thrombosis, pulmonary embolism, and ce-
rebral venous thrombosis.
5,6
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BackgroundzzCarotid cavernous fistula (CCF) is an abnormal communication between the 
carotid artery and the cavernous sinus. The pathogenesis of spontaneous CCF remains unclear, 
although sinus thrombosis is known to be a predisposing factor for dural arteriovenous fistula. 
Because spontaneous CCFs are mainly of the dural type, we considered that thrombogenic con-
ditions, such as, protein S deficiency might be associated with CCF.
Case ReportzzA 42-year-old woman complained of conjunctival injection and retro-orbital 
pain that first appeared 1-month before visiting our hospital. She had no history of head trauma 
or intracranial surgery. Exophthalmos and chemosis were observed in her left eye, which also 
had lower visual acuity and higher intraocular pressure than the right eye. Magnetic resonance 
images and cerebral angiography revealed a left dural CCF. Her protein S was low, at 41% 
(normal range: 70-140%), but other hematologic values related to coagulation were normal. 
Her symptoms were relieved after initial transvenous coil embolization. However, a newly de-
veloped sixth-nerve palsy was detected 4 days after initial embolization. Follow-up angiogra-
phy revealed a minimal shunt, and thus transvenous coil embolization was repeated. Two days 
later, the ophthalmoplegia started reducing, and 1-month later it had almost disappeared.
ConclusionszzTo the best of our knowledge, this is the first report of spontaneous dural CCF 
in a Korean patient with concurrent protein S deficiency. Interestingly, transient sixth-nerve 
palsy developed after transvenous coil embolization in this patient. This additional symptom 
caused by the residual fistula was relieved after additional transarterial embolization.
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It is known that sinus thrombosis, head trauma, surgery, 
and hormonal influences are factors that predispose to dural 
arteriovenous fistula (AVF).
7,8 Because spontaneous CCFs 
are usually of the dural type, we considered that thrombo-
genic conditions, such as, protein S deficiency, might be re-
lated to spontaneous CCF. In this context, we describe a case 
of spontaneous CCF in a patient with protein S deficiency.
Case Report
A 42-year-old Korean woman complained of conjunctival 
injection and a dull retro-orbital pain of 1-month duration in 
her left eye. Decreased visual acuity of the left eye devel-
oped 20-days thereafter, but she did not complain of diplo-
pia. Furthermore, she had no history of head trauma, intra-
cranial surgery, or intake of hormonal drugs. Essential hyper-
tension had been detected 6-months previously, and she was 
taking antihypertensive medication, but her blood pressure 
was well controlled. Neither the patient nor her family mem-
bers had any history of thromboembolic disease.
The patient’s systolic and diastolic blood pressures were 
118 and 76-mmHg, respectively. Exophthalmos, chemosis, 
and conjunctival injection were observed in her left eye. The 
visual acuities of her left and right eyes were 20/1,000 and 
20/200, respectively, and the intraocular pressures were 25 
and 12-mmHg. Light reflexes in both eyes were normal, and 
no relative afferent papillary defect was observed. Limita-
tions of extraocular motion were not evident and the fundi of 
both eyes were normal. Ophthalmic bruit was heard on her 
left eye. Both motor and sensory functions were intact, and 
deep tendon reflexes were normal. Furthermore, there was 
no evidence of cerebellar dysfunction, and she did not have 
an abnormal gait.
Magnetic resonance and cerebral angiography images re-
vealed a left CCF that was fed by the bilateral internal and 
external carotid arteries (dural CCF) (Fig. 1). The CCF drain-
ed into the left superior ophthalmic vein and the left spheno-
parietal sinus. No thrombosis was observed in the cavernous 
sinus. Hematologic tests showed normal levels of protein C 
and antithrombin III. Factor V Leiden and antiphospholipid 
antibody were not detected. Her protein S level was low at 
41% (normal range: 70-140%). 
The cavernous sinus was embolized via a transvenous ap-
proach using 19 coils, and the fistula was completely obliter-
ated. Chemosis, conjunctival injection, and orbital pain were 
relieved after embolization, and the patient’s visual acuity 
improved from 20/1,000 to 20/100, and the intraocular pres-
sure decreased from 25 to 17-mmHg.
Sixth-nerve palsy with orbital pain developed suddenly 4 
days after the initial embolization; the intraocular pressures 
in the left and right eyes were 17 mmHg and 12 mmHg, respe-
ctively. Follow-up angiography revealed a minimal shunt 
from the dural branch of the left middle meningeal artery. 
Thus, transarterial glue injection and second coil emboliza-
tion were performed via a transfacial vein, which resulted in 
completely obliteration of the shunt. Anticoagulation therapy 
was then started to prevent additional venous thrombosis due 
to the protein S deficiency. Two days after the second embo-
lization (6-days after the initial embolization) diplopia and 
orbital pain started diminishing, and at 1-month after embo-
lization, only minimal diplopia in the extreme left lateral 
gaze remained. 
Discussion
We report a case of spontaneous dural CCF and concurrent 
protein S deficiency. Several studies have shown that dural 
AVF is associated with thrombosis of the involved sinus.
9,10 
One possible mechanism for the development of acquired 
dural AVF is that increased venous pressure after sinus 
thrombosis opens intrinsic channels between the cerebral ar-
teries and venous sinuses.
11 Another is that increased venous 
pressure may elicit local ischemia and increase ischemia-re-
lated angiogenesis.
12 Accordingly, we considered that dural 
AVF might be associated with thrombogenic conditions such 
as protein S deficiency, resulting in the development of sinus 
thrombosis. 
A few retrospective studies have investigated the associa-
Fig. 1. Cerebral angiography images show a left CCF fed by the 
bilateral internal and external carotid arteries. A: Lateral arterio-
gram of left external carotid artery. B: Lateral arteriogram of left 
internal carotid artery. C: Anteroposterior arteriogram of right in-
ternal carotid artery. D: Magnetic resonance images indicate a 
prominent superior ophthalmic vein. CCF: carotid cavernous fis-
tula.
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tion between dural AVF and thrombogenic conditions.
13-15 A 
German study found that the prevalence of the G20210A 
mutation was higher in patients with spontaneous dural AVF 
than in a control group, but only one patient had protein S 
deficiency.
14 In a recent Japanese study, 4 (22.2%) of 18 pa-
tients with spontaneous dural CCF were found to have pro-
tein S deficiency, but this did not reach statistical signifi-
cance
15, which was attributed to the small sample size and 
the prevalence of protein S deficiency being higher in the 
Japanese control group than in Caucasians. However, no re-
port of an association between spontaneous dural AVF and 
thrombogenic conditions has been issued in any other country.
Sinus thrombosis is considered to play an important role in 
the development of dural AVF in patients with thrombogenic 
conditions. Interestingly, our patient did not have sinus throm- 
bosis. However, dural AVF and sinus thrombosis might not 
always develop simultaneously.
15 There is a report of dural 
AVF developing more than 12-months after sinus thrombo-
sis.
16 It is possible that the inciting thrombosis had already 
resolved when the CCF was detected.
In our patient a new sixth-nerve palsy developed after the 
initial embolization. In a previous study, six cases (10.7%) 
developed cranial nerve signs after transvenous emboliza-
tion, including sixth-nerve palsy.
17 In most cases, overpack-
ing of the cavernous sinus probably caused the transient cra-
nial nerve symptoms; progressive thrombosis of the caver- 
nous sinus and direct injury of the nerve by a coil or micro-
wire/microcatheter are also possible causes.
18,19 Although a 
recent study measured coil volumes and locations, a method 
devised to demonstrate coil overpacking was not feasible.
20 
Thus, it is unclear whether the cause of newly developed 
sixth nerve palsy in our case was overpacking, a residual 
shunt, or progressive thrombosis related to protein S defi-
ciency. The disappearance of symptoms after the second em-
bolization and the intraocular pressure being higher in the 
left eye than in the right eye after embolization and anticoag-
ulation support the theory of residual shunt or progressive 
thrombosis theories, but the overpacking theory is supported 
by the following findings: 1) The size of the newly devel-
oped shunt was negligible compared to that of the initial 
CCF. 2) The intraocular pressure of left eye (17 mmHg) was 
higher than that of the right eye, which was within normal 
limit. 3) The newly developed cranial nerve palsies caused 
by overpacking in previously described cases disappeared 
spontaneously.
19 
To our knowledge, this is the first report of spontaneous 
CCF in a Korean patient with concurrent protein S deficiency. 
Few studies have investigated the association between CCF 
and thrombogenic conditions, which makes further adequate-
ly powered studies necessary. Interestingly, a transient sixth-
nerve palsy developed after transvenous coil embolization, 
but this additional symptom-which was caused by residual 
fistula-was relieved after additional transarterial embolization.
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